Skip to main content
. 2016 Jan 11;11(Suppl 4):151–162. doi: 10.1111/mcn.12163

Table 2.

Baseline characteristics by intervention group of per protocol analysis

MNP + Fe MNP − Fe Both
n 144 143 287
Age (months) 6.0 ± 1.1 6.0 ± 1.1 6.0 ± 1.1
Sex (male) 74 (51.4%) 72 (50.3%) 146 (50.9%)
Haemoglobin (g L–1) 104.1 ± 10.5 102.1 ± 10.6 103.0 ± 10.5
Zinc protoporphyrin (μmol mol–1 haem) 85.1 ± 1.6* 103.8 ± 1.8 94.1 ± 1.7
Serum ferritin (ng mL–1)
All children 34.1 ± 1.8 27.8 ± 2.0 30.9 ± 1.9
Children without inflammation 30.5 ± 1.7 25.2 ± 2.1 27.8 ± 1.9
Soluble transferrin receptor (mg L–1) 8.6 ± 1.2* 9.6 ± 1.2 9.1 ± 1.2
C‐reactive protein (mg L–1) 4.9 ± 1.7 3.7 ± 1.4 4.3 ± 1.6
Inflammation 45 (31.2%) 44 (30.8%) 89 (31.0%)
Anaemia 99 (68.8%) 104 (72.7%) 203 (70.7%)
ID § 18 (12.8%)** 43 (30.9%) 61 (21.8%)
IDA 15 (10.6%)** 38 (27.3%) 53 (18.9%)
Weight baseline (kg) 7.3 ± 1.1 7.3 ± 1.1 7.3 ± 1.1
Length baseline (cm) 64.8 ± 1.0 64.1 ± 1.1 64.4 ± 1.1
Birthweight (kg) 3.2 ± 1.0 3.1 ± 1.0 3.2 ± 1.0
Body iron stores (mg kg–1) 3.26 ± 1.0* 1.86 ± 1.0 2.57 ± 1.0

Data are geometric means ± SD or number (%) unless indicated otherwise. ID, iron deficiency; IDA, iron deficiency anaemia; MNP + Fe, micronutrient powder with iron; MNP − Fe, micronutrient powder without iron. *Different from control (MNP − Fe), P < 0.05 using t‐test. **Different from control (MNP − Fe), P < 0.05 using Pearson's chi‐square test. CRP ≥ 4.1 mg L–1. Hb <110 g L–1. §Body iron stores (mg kg–1) < 0. Concurrent ID and anaemia.